Information:
Fel:
ID
30864
Beskrivning
Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00724568
Länk
https://clinicaltrials.gov/show/NCT00724568
Nyckelord
Versioner (1)
- 2018-06-28 2018-06-28 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
28 juni 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Multiple Myeloma NCT00724568
Eligibility Multiple Myeloma NCT00724568
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Myeloma NCT00724568
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age | Multiple Myeloma
Item
you will be eligible to participate in this study if you are at least 18 years old and have newly diagnosed multiple myeloma.
boolean
C0001779 (UMLS CUI [1])
C0026764 (UMLS CUI [2])
C0026764 (UMLS CUI [2])
Hematologic Tests | Screening test | Test Results Within defined limits Study Protocol
Item
you will have blood tests and other screening tests before you are enrolled and your test results must be within the limits outlined for eligibility to participate in this experimental study.
boolean
C0018941 (UMLS CUI [1])
C0871311 (UMLS CUI [2])
C0456984 (UMLS CUI [3,1])
C4047968 (UMLS CUI [3,2])
C2348563 (UMLS CUI [3,3])
C0871311 (UMLS CUI [2])
C0456984 (UMLS CUI [3,1])
C4047968 (UMLS CUI [3,2])
C2348563 (UMLS CUI [3,3])
Chronic Obstructive Airway Disease | Restrictive lung disease chronic | Liver Cirrhosis
Item
chronic obstructive or chronic restrictive pulmonary disease and cirrhosis.
boolean
C0024117 (UMLS CUI [1])
C0085581 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0023890 (UMLS CUI [3])
C0085581 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0023890 (UMLS CUI [3])
Hypersensitivity Bortezomib | Hypersensitivity Boron | Mannitol allergy | Hypersensitivity Doxil Component
Item
patient has hypersensitivity to bortezomib, boron or mannitol or any of the components of doxil.
boolean
C0020517 (UMLS CUI [1,1])
C1176309 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0006030 (UMLS CUI [2,2])
C0571922 (UMLS CUI [3])
C0020517 (UMLS CUI [4,1])
C0279284 (UMLS CUI [4,2])
C1705248 (UMLS CUI [4,3])
C1176309 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0006030 (UMLS CUI [2,2])
C0571922 (UMLS CUI [3])
C0020517 (UMLS CUI [4,1])
C0279284 (UMLS CUI [4,2])
C1705248 (UMLS CUI [4,3])
Pregnancy | Breast Feeding
Item
female subject is pregnant or breast-feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Investigational New Drugs
Item
patient has received other investigational drugs with 14 days before
boolean
C0013230 (UMLS CUI [1])
Diabetic - poor control
Item
uncontrolled diabetes mellitus.
boolean
C0421258 (UMLS CUI [1])
Aciclovir allergy | Hypersensitivity Antiviral Agents Similar
Item
hypersensitivity to acyclovir or similar anti-viral drug.
boolean
C0571297 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0003451 (UMLS CUI [2,2])
C2348205 (UMLS CUI [2,3])
C0020517 (UMLS CUI [2,1])
C0003451 (UMLS CUI [2,2])
C2348205 (UMLS CUI [2,3])
HIV Infection
Item
known hiv infection.
boolean
C0019693 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
known active hepatitis b or c viral infection.
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0019196 (UMLS CUI [2])
Intolerance Steroid therapy
Item
known intolerance to steroid therapy.
boolean
C0231199 (UMLS CUI [1,1])
C0149783 (UMLS CUI [1,2])
C0149783 (UMLS CUI [1,2])
Hypersensitivity Pharmaceutical Preparations Prophylactic treatment
Item
known hypersensitivity to required prophylactic medications.
boolean
C0020517 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0199176 (UMLS CUI [1,3])
C0013227 (UMLS CUI [1,2])
C0199176 (UMLS CUI [1,3])